- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04821011
Assessment of Autonomic Regulation During the Listening of Mother Heart Beat in Newborns (Cardio_Sound)
Prematurity birth lead to an early breaking link with the in utero environment. A special attention is brought in the neonatal intensive care units to reduce noise and lighting surrounding aiming to protect the newborn.
During the uterine life fetus benefits previously of several auditory stimulations by the maternal voice, the mother's heartbeat. After birth the auditory environment is dramatically modified.
Aim of this study is to submit to the newborn an audio recording of his mother's heart beat to analyze the comfort, stress and autonomic response. Heart rate variability (HRV) analysis is a non-invasive tool able to consider autonomic nervous system activity. Previous studies have shown that pleasant feelings are associated with an increase of high frequencies variations index (HFnu index) reflecting a prevalence of parasympathetic activity in the sympathetic-parasympathetic balance. This one can be simply assess by a monitor named NIPΣ and can provide a comfort index by quantifying the parasympathetic tone.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Saint-Étienne, France
- CHU SAINT-ETIENNE
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Neonates between 28 and 40 Weeks of Gestational Age (wGA)
- Hospitalized in the neonatal intensive care units of the university hospital of Saint-Etienne (France)
Exclusion Criteria:
- Respiratory or hemodynamic instability
- Uncontrolled sepsis
- Sedation on going
- Treatment known to modify the sympathetic or parasympathetic activity of the autonomic nervous system
- Congenital disease
- Congenital ear pathology
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Newborn birth between 28 and 40 Weeks of Gestational Age (wGA)
Newborn birth between 28 and 40 Weeks of Gestational Age (wGA) will be included. The mother's newborn will be have a record of her heartbeats. The newborn will be have an acoustic listening of their mother's heartbeat and a record of their own heartbeats. |
Record of maternal heart sounds (heartbeats) with an electronic stethoscope during 10 minutes.
Other Names:
Each newborn included will have 20 minutes of an acoustic listening of their mother heartbeats previously recorded.
Recording of the newborn's heart rate: one hour before the acoustic listening, during the acoustic listening and one hour after the acoustic listening . The variations of the autonomic nervous system will be analyzed. An coupled Heart rate variability recording (ECG signal obtained from a Philips® IntelliVue MX700 monitor) and NIPΣ index of comfort (MDMS® NIPΣ monitor) will be used.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
NIPΣ index
Time Frame: During the acoustic listening
|
Analyze variations of the activity of the autonomic nervous system (R-R cardiac interval) NIPΣ index (from 0 to 100) obtained from an MDoloris® monitor. The base line is measured one hour before |
During the acoustic listening
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HFnu (normalized high frequency) index.
Time Frame: During the acoustic listening
|
Measured by analyze of record's of newborn heart rate. The base line is measured one hour before |
During the acoustic listening
|
HFnu (normalized high frequency) index.
Time Frame: One hour after the acoustic listening
|
Measured by analyze of record's of newborn heart rate.
|
One hour after the acoustic listening
|
Standard deviation of all NN intervals (SDNN)
Time Frame: During the acoustic listening
|
Measured by analyze of record's of newborn heart rate
|
During the acoustic listening
|
Standard deviation of all NN intervals (SDNN)
Time Frame: One hour after the acoustic listening
|
Measured by analyze of record's of newborn heart rate
|
One hour after the acoustic listening
|
Proportion of NN50 divided by the total number of NN intervals (pNN50)
Time Frame: During the acoustic listening
|
Measured by analyze of record's of newborn heart rate
|
During the acoustic listening
|
Proportion of NN50 divided by the total number of NN intervals (pNN50)
Time Frame: One hour after the acoustic listening
|
Measured by analyze of record's of newborn heart rate
|
One hour after the acoustic listening
|
Root mean square of the successive differences (RMSSD).of RR interval
Time Frame: One hour after the acoustic listening
|
Measured by analyze of record's of newborn heart rate.
|
One hour after the acoustic listening
|
Root mean square of the successive differences (RMSSD).of RR interval
Time Frame: During the acoustic listening
|
Measured by analyze of record's of newborn heart rate.
|
During the acoustic listening
|
Total power spectrum (Ptot)
Time Frame: During the acoustic listening
|
Measured by analyze of record's of newborn heart rate.
|
During the acoustic listening
|
Total power spectrum (Ptot)
Time Frame: One hour after the acoustic listening
|
Measured by analyze of record's of newborn heart rate.
|
One hour after the acoustic listening
|
Low Frequency (LF)
Time Frame: During the acoustic listening
|
Measured by analyze of record's of newborn heart rate.
|
During the acoustic listening
|
Low Frequency (LF)
Time Frame: One hour the acoustic listening
|
Measured by analyze of record's of newborn heart rate.
|
One hour the acoustic listening
|
High Frequency (HF)
Time Frame: During the acoustic listening
|
Measured by analyze of record's of newborn heart rate.
|
During the acoustic listening
|
High Frequency (HF)
Time Frame: One hour after the acoustic listening
|
Measured by analyze of record's of newborn heart rate.
|
One hour after the acoustic listening
|
Very Low Frequency (VLF)
Time Frame: During the acoustic listening
|
Measured by analyze of record's of newborn heart rate.
|
During the acoustic listening
|
Very Low Frequency (VLF)
Time Frame: One hour after the acoustic listening
|
Measured by analyze of record's of newborn heart rate.
|
One hour after the acoustic listening
|
Ratio Low Frequency (LF) / High Frequency (HF)
Time Frame: During the acoustic listening
|
Measured by analyze of record's of newborn heart rate.
|
During the acoustic listening
|
Ratio Low Frequency (LF) / High Frequency (HF)
Time Frame: One hour after the acoustic listening
|
Measured by analyze of record's of newborn heart rate.
|
One hour after the acoustic listening
|
Heart rate (bpm)
Time Frame: During the acoustic listening
|
Measured by analyze of record's of newborn heart rate.
|
During the acoustic listening
|
Oxygen saturation (%)
Time Frame: During the acoustic listening
|
Measured by analyze of record's of newborn heart rate.
|
During the acoustic listening
|
NIPΣ index
Time Frame: One hour after the acoustic listening
|
Analyze variations of the activity of the autonomic nervous system (R-R cardiac interval) NIPΣ index (from 0 to 100) obtained from an MDoloris® monitor. |
One hour after the acoustic listening
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRBN462021/CHUSTE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Birth
-
Shaare Zedek Medical CenterTerminatedPremature Birth of NewbornIsrael
-
University of VirginiaCompletedPremature Birth of NewbornUnited States
-
Case Western Reserve UniversityCompleted
-
University of California, San FranciscoUniversity of California, San Diego; University of California, Los Angeles; Kaiser...CompletedPremature Birth of NewbornUnited States
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenUnknownPremature Birth of NewbornBelgium
-
Universidad Complutense de MadridCompletedPremature Birth of Newborn
-
Indiana UniversityCompletedPremature LaborUnited States
-
Washington University School of MedicineUniversity of Southern CaliforniaCompletedPremature Birth of NewbornUnited States
-
Vestre Viken Hospital TrustHaukeland University HospitalActive, not recruiting
-
University of ArkansasCompletedPremature Birth of NewbornUnited States
Clinical Trials on electronic stethoscope
-
3MCompleted
-
Eko Devices, Inc.CompletedLeft Ventricular DysfunctionUnited States
-
Eko Devices, Inc.CompletedHeart Diseases | Cardiovascular Diseases | Ventricular Dysfunction | Left Ventricular DysfunctionUnited States
-
Eko Devices, Inc.RecruitingHeart Murmurs | Murmur, Heart | Innocent Murmurs | Pathologic MurmurUnited States
-
Eko Devices, Inc.CompletedHeart Failure | Left Ventricular DysfunctionUnited States
-
Eko Devices, Inc.CompletedHeart Diseases | Cardiovascular Diseases | Ventricular Dysfunction | Left Ventricular DysfunctionUnited States
-
University of NottinghamHeartlight Systems LimitedSuspended
-
Strados Labs, Inc.RecruitingAsthma | Asthma in Children | Wheezing | Pediatric AsthmaUnited States